TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering [Yahoo! Finance]
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering [Yahoo! Finance]
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting [Yahoo! Finance]